Who
Penny Tom
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, Equillium.
In numbers
- Trades disclosed
- 27
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $438K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Sep 2024
- Last trade
- 28 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $51K65,000 at $0.785 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $192K65,000 at $2.95 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —65,000 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code M | —65,000 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Code M | $51K65,000 at $0.79 | filing |
| 28 May 2026filed 29 May 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $192K65,000 at $2.95 | filing |
| 8 Jan 2026filed 9 Jan 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $8,4286,533 at $1.29 | filing |
| 8 Jan 2026filed 9 Jan 2026 | EQ EquilliumBiotechnology | SEC FORM 4 Sold | $8,4286,533 at $1.29 | filing |
| 7 Jan 2026filed 9 Jan 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 29 Aug 2025filed 3 Sep 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —525,000 at $0.00 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —65,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —45,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —40,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code D | —60,000 | filing |
| 14 Feb 2025filed 19 Feb 2025 | EQ Equilliumoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 | filing |
News
Leerink Partners Initiates Coverage on Equillium (NASDAQ:EQ)EQ · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Penny Tom; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.